tiprankstipranks
Trending News
More News >

Sawai Group Holdings Revises Financial Results Due to Litigation Costs

Story Highlights
Sawai Group Holdings Revises Financial Results Due to Litigation Costs

Confident Investing Starts Here:

The latest update is out from SAWAI GROUP HOLDINGS Co., Ltd. ( (JP:4887) ).

Sawai Group Holdings Co., Ltd. announced a correction to its consolidated financial results for the fiscal year ended March 31, 2025, due to a provision for loss on litigation amounting to JPY 16,757 million. This adjustment significantly impacted the company’s financial statements, reflecting a decrease in operating profit and profit before tax, highlighting challenges in their financial performance and potential implications for stakeholders.

The most recent analyst rating on (JP:4887) stock is a Sell with a Yen1650.00 price target. To see the full list of analyst forecasts on SAWAI GROUP HOLDINGS Co., Ltd. stock, see the JP:4887 Stock Forecast page.

More about SAWAI GROUP HOLDINGS Co., Ltd.

Sawai Group Holdings Co., Ltd. operates in the pharmaceutical industry, focusing primarily on the production and distribution of generic drugs. The company is listed on the Tokyo Stock Exchange and aims to provide affordable medication solutions, contributing to the healthcare sector by enhancing access to essential medicines.

Average Trading Volume: 613,272

Technical Sentiment Signal: Sell

Current Market Cap: Yen177.6B

See more insights into 4887 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App